Recombinant soluble form of heparin-binding epidermal growth factor-like growth factor protein therapy drastically inhibits Fas-mediated fulminant hepatic failure: Implications in clinical application
Hepatol Res
.
2011 Jun;41(6):594-6.
doi: 10.1111/j.1872-034X.2011.00805.x.
Epub 2011 Apr 28.
Authors
Ngin Cin Khai
1
,
Kouichi Sakamoto
,
Hideo Takamatsu
,
Hiroshi Matsufuji
,
Ken-Ichiro Kosai
Affiliation
1
Departments of Gene Therapy and Regenerative Medicine Pediatric Surgery, Kagoshima University Graduate School of Medical and Dental Science Kagoshima University Medical and Dental Hospital, Kagoshima, Japan.
PMID:
21535334
DOI:
10.1111/j.1872-034X.2011.00805.x
No abstract available
Publication types
Letter